MicroRNA 2681 (MIR2681)

MicroRNA 2681 (MIR2681) is a short, non-coding RNA molecule classified as a microRNA (miRNA). miRNAs are 20–24 nucleotide RNAs that function in post-transcriptional gene regulation primarily by binding to target messenger RNAs (mRNAs) and leading to their degradation or inhibition of translation. This process involves the incorporation of the mature miRNA into the RNA-induced silencing complex (RISC), which recognizes mRNA targets by base pairing. MIR2681 is annotated in the human genome and is catalogued by miRBase as hsa-mir-2681. As of current knowledge, MIR2681 is not established as a therapeutic target, and there are no known drug interactions or disease mechanisms specifically characterized through this microRNA, although the broader microRNA class is highly involved in diverse biological regulation and disease processes. Notes: - MIR2681 is a canonical microRNA gene and not a protein target or receptor; it regulates gene expression epigenetically rather than serving as a classical drug target. - Its association with disease (corneal dystrophy, congenital stromal) is currently limited to gene/disease annotation rather than validated mechanistic or therapeutic data. - There is no evidence for approved drugs targeting or acting via MIR2681, nor clear evidence for use as a clinical biomarker in current literature.

Other names

hsa-mir-2681hsa-mir-2681 (alternative capitalization)MIR2681